A Study of Baricitinib and Ciclosporin in Healthy Participants
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of ciclosporin on the amount of
baricitinib that is absorbed into the blood stream and the time it takes to remove
baricitinib from the body. The study will also look at how well-tolerated and safe
baricitinib is, when given alone and in combination with ciclosporin. Side effects will be
documented. The study will last approximately 6 days from the first dose to the end of the
study (not including screening or follow-up).